Search results
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 6 hours agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
The Kansas City Star· 9 hours agoManufacturing is underway and doses of Moderna’s Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval
What to know about upcoming COVID-19 vaccines and the FLiRT variants
GBH News· 11 hours agoThe federal government and vaccine makers are getting a new COVID-19 vaccine ready for the fall. An...
New COVID variant KP.3 climbs to 25%, now largest in CDC estimates
CBS News· 7 hours agoThe new KP.3 variant has climbed to 1 in 4 new COVID-19 cases nationwide, the Centers for Disease...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 2 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 19 hours agoModerna has a couple of factors to back its strong run. Firstly, the U.S. FDA recently approved ...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 2 days agoThe Vaccines and Related Biological Products Advisory Committee – composed of leading U.S. health...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Reuters via AOL· 9 hours agoThe Food and Drug Administration's advisory is in line with European and World Health Organization...
A New COVID Booster Targeting JN.1 May Arrive This Fall
Verywell Health via Yahoo News· 7 hours agoAn FDA panel voted to recommend an updated COVID-19 vaccine targeting the JN.1 variant. Here's what...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 4 days agoInsights from TIME, The Washington Post, MIT Technology Review The News Pharmaceutical giants ...